These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 923610)

  • 61. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
    Neoplasma; 1987; 34(1):95-9. PubMed ID: 3104809
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer.
    Holtkamp W; Nagel GA; Wander HE; Rauschecker HF; von Heyden D
    Int J Cancer; 1984 Sep; 34(3):323-8. PubMed ID: 6480153
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Circulating levels of prolactin in human breast cancer.
    Sheth NA; Ranadive KJ; Suraiya JN; Sheth AR
    Br J Cancer; 1975 Aug; 32(2):160-7. PubMed ID: 2274
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enzymes of carbohydrate metabolism in human breast carcinoma: relationship with serum hormones.
    Ramalingam V; Krishnamoorthy G; Govindarajulu P
    Neoplasma; 1994; 41(1):49-54. PubMed ID: 8202196
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preliminary observations on alterations in prolactin, gonadotropins, E2-17B & progesterone in patients with breast cancer.
    Dash RJ; Behera D; Khanchi RK; Singh K
    Indian J Med Res; 1987 Dec; 86():749-54. PubMed ID: 3131240
    [No Abstract]   [Full Text] [Related]  

  • 66. Relation between tumour size and plasma prolactin levels in premenopausal patients with breast carcinoma. A preliminary report.
    Olsson H; Ewers SB; Landin-Olsson M; Ranstam J
    Acta Radiol Oncol; 1985; 24(1):57-9. PubMed ID: 2984903
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Hormonal profiles and structures in normal women and in patients with benign and malignant breast diseases].
    Imayoshi E; Soga H; Nomura S; Komatsubara S; Satoh G; Teramoto S; Fukuda K; Takashima S
    Nihon Gan Chiryo Gakkai Shi; 1984 Jun; 19(5):1014-20. PubMed ID: 6501991
    [No Abstract]   [Full Text] [Related]  

  • 68. Estrogen and progesterone receptors in human breast cancer with concomitant assay of plasma 17beta-estradiol, progesterone, and prolactin levels.
    Nagai R; Kataoka M; Kobayashi S; Ishihara K; Tobioka N; Nakashima K; Naruse M; Saito K; Sakuma S
    Cancer Res; 1979 May; 39(5):1834-40. PubMed ID: 427816
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
    Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hormones and breast cancer.
    Key TJ; Allen NE
    IARC Sci Publ; 2002; 156():273-6. PubMed ID: 12484186
    [No Abstract]   [Full Text] [Related]  

  • 71. [Buserelin therapy in postmenopausal patients with advanced breast carcinoma].
    Vici P; Veltri E; Carpano S; Di Lauro L; Lopez M
    Clin Ter; 1991 Feb; 136(3):195-9. PubMed ID: 1827382
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oestrogen receptors and peripheral serum levels of oestradiol-17beta in patients with mammary carcinoma.
    Theve NO; Carlström K; Gustafsson JA; Gustafsson S; Nordenskjöld B; Sköldefors H; Wrange O
    Eur J Cancer (1965); 1978 Dec; 14(12):1337-40. PubMed ID: 738338
    [No Abstract]   [Full Text] [Related]  

  • 73. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
    Tarquini B; Benvenuti M; Legnaioli M; Bazzani M; Cagnoni M; Halberg F
    Cancer Detect Prev; 1981; 4(1-4):525-34. PubMed ID: 7349819
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endogenous sex hormones, prolactin, and breast cancer in premenopausal women.
    Meyer F; Brown JB; Morrison AS; MacMahon B
    J Natl Cancer Inst; 1986 Sep; 77(3):613-6. PubMed ID: 3462404
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Climacteric symptoms, fat mass, and plasma concentrations of LH, FSH, Prl, oestradiol-17 beta and androstenedione in the early post-menopausal period.
    Hagen C; Christiansen C; Christensen MS; Transbøl I
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):87-92. PubMed ID: 6812347
    [No Abstract]   [Full Text] [Related]  

  • 76. Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease.
    Reed MJ; Cheng RW; Noel CT; Dudley HA; James VH
    Cancer Res; 1983 Aug; 43(8):3940-3. PubMed ID: 6683128
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Endogenous sex hormones, prolactin, and mammographic features of breast tissue in premenopausal women.
    Meyer F; Brisson J; Morrison AS; Brown JB
    J Natl Cancer Inst; 1986 Sep; 77(3):617-20. PubMed ID: 3462405
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Abnormalities in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease.
    Tarquini A; di Martino L; Malloci A; Kwa HG; van der Gugten AA; Bulbrook RD; Wang DY
    Int J Cancer; 1978 Dec; 22(6):687-90. PubMed ID: 721323
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Endocrinology of benign breast disease in relation to the severity of radiological dysplasia.
    Junkermann H; Klinga K; Weber E; von Fournier D
    Horm Res; 1989; 32 Suppl 1():10-4. PubMed ID: 2613196
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Dynamics of gonadotropins and prolactin in dysplasias and cancer of the breast].
    Korolev VI; Skliar SIu; Ponomarev IN
    Vrach Delo; 1988 Jan; (1):59-61. PubMed ID: 3363942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.